文献速递胸部CTPET

局部晚期肺癌中调强放疗与三维适形放疗的比较效果:病理与临床结局

Comparative effectiveness of intensity modulated radiation therapy to 3-dimensional conformal radiation in locally advanced lung cancer: pathological and clinical outcomes.
PubMed 文献 · Br J Radiol · 2019-04-01

该回顾性研究纳入2012年8月至2018年8月在以色列Sheba医学中心接受三联治疗(同步放化疗至60 Gy后完成手术)的74例局部晚期非小细胞肺癌患者,比较3DCRT与IMRT的病理退缩、手术切缘、局部控制及生存。两组主要病理缓解率、病理完全缓解率、切缘阴性率及2年局部控制率、无病生存、3年总生存均无显著差异。

要点

  • 3DCRT组与IMRT组主要病理缓解率分别为62.7%与65.2%,无显著差异(p=0.83)。
  • 两组病理完全缓解率分别为33.3%与34.8%,无显著差异(p=0.9)。
  • 两组切缘阴性率分别为90.1%与89.4%,无显著差异(p=1.0)。

核心结论

  • 在新辅助治疗局部晚期非小细胞肺癌时,IMRT与3DCRT产生相当的病理和临床结局。

研究设计与样本

  • 回顾性研究,纳入2012年8月至2018年8月以色列Sheba医学中心74例局部晚期非小细胞肺癌患者,采用同步放化疗至60 Gy后完成手术的三联治疗策略,计划靶区由配准的PET/CT定义,比较3DCRT与IMRT的病理退缩、手术切缘、局部控制率、无病生存和总生存。

诊断标准与关键数值

  • 主要病理缓解定义为病理完全缓解或残留肿瘤细胞少于10%,3DCRT组32/51(62.7%) vs IMRT组15/23(65.2%),p=0.83。
  • 病理完全缓解率3DCRT组17/51(33.3%) vs IMRT组8/23(34.8%),p=0.9。
  • 手术切缘阴性率3DCRT组46/51(90.1%) vs IMRT组17/19(89.4%),p=1.0。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Intensity-modulated radiotherapy (IMRT) has better normal-tissue sparing compared with 3-dimensional conformal radiation (3DCRT). We sought to assess the impact of radiation technique on pathological and clinical outcomes in locally advanced non-small cell lung cancer (LANSCLC) treated with a trimodality strategy.

METHODS: Retrospective review of LANSCLC patients treated from August 2012 to August 2018 at Sheba Medical Center, Israel. The trimodality strategy consisted of concomitant chemoradiation to 60 Gray (Gy) followed by completion surgery. The planning target volume (PTV) was defined by co-registered PET/CT. Here we compare the pathological regression, surgical margin status, local control rates (LC), disease free (DFS) and overall survival (OS) between 3DCRT and IMRT.

RESULTS: Our cohort consisted of 74 patients with mean age 62.9 years, male in 51/74 (69%), adenocarcinoma in 46/74 (62.1%), stage 3 in 59/74 (79.7%) and chemotherapy in 72/74 (97.3%). Radiation mean dose: 59.2 Gy (SD ± 3.8). Radiation technique : 3DCRT in 51/74 (68.9%), IMRT in 23/74 (31%). Other variables were similar between groups.Major pathological response (including pathological complete response or less than 10% residual tumor cells) was similar: 32/51 (62.7%) in 3DCRT and 15/23 (65.2%) in IMRT, p=0.83. Pathological complete response (pCR) rates were similar: 17/51 (33.3%) in 3DCRT and 8/23 (34.8%) in IMRT, p=0.9. Surgical margins were negative in 46/51 (90.1%) in 3DCRT vs. 17/19 (89.4%) in IMRT (p=1.0).The 2-year LC rates were 81.6% (95% CI 69-89.4%); DFS 58.3% (95% CI 45.5-69%) and 3-year OS 70% (95% CI57-80%). Comparing radiation techniques, there were no significant differences in LC (p=0.94), DFS (p=0.33) and OS (p=0.72).

CONCLUSION: When used to treat LANSCLC in the neoadjuvant setting, both IMRT and 3DCRT produce comparable pathological and clinical outcomes.

ADVANCES IN KNOWLEDGE: This study validates the real-world effectiveness of IMRT compared to 3DCRT.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Appel S, Bar J, Ben-Nun A, et al. Comparative effectiveness of intensity modulated radiation therapy to 3-dimensional conformal radiation in locally advanced lung cancer: pathological and clinical outcomes. Br J Radiol. 2019. PMID: 30864828. doi:10.1259/bjr.20180960

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。